One of the challenges when comparing the subtype-specificity of different β-adrenoceptor antagonists ... drugs. Results obtained by this method therefore more accurately reflect tissue-binding ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

Radioligand binding assays showed that LY2033298 potentiated acetylcholine binding, but did not affect antagonist binding ... a novel class of antipsychotic drugs.

The final arbiter of the clinical usefulness of a drug in the 'real world' is postmarketing ... which begins with studies evaluating in vitro binding and concludes with large postmarketing ...